| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 7,928 | 6,850 | 7,401 | 23,323 | | Cost of Revenue | 1,860 | 2,858 | 1,713 | 1,692 | | | Gross Profit | 6,068 | 3,992 | 5,688 | 21,631 | | | Operating Expenses | | Research Development | 36,430 | 24,427 | 26,274 | 25,665 | | Selling General and Administrative | 8,519 | 8,476 | 7,795 | 7,879 | | Non Recurring | (13,373) | 14,113 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (25,508) | (43,024) | (28,381) | (11,913) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,665) | 5,939 | (2,401) | 1,230 | | Earnings Before Interest And Taxes | (34,173) | (37,085) | (30,782) | (10,683) | | Interest Expense | 2,487 | 2,733 | 1,592 | 1,520 | | Income Before Tax | (36,660) | (39,818) | (32,374) | (12,203) | | Income Tax Expense |
-
| 2,194 |
-
| 325 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (36,660) | (42,012) | (32,374) | (12,528) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 32 | (3) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (36,660) | (42,012) | (32,342) | (12,531) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($36,660) | ($42,012) | ($32,342) | ($12,531) |
|
0.11% Nasdaq 
0.01%
Income Statement
